NCT04662242View on ClinicalTrials.gov

The Prognostic Impact of Selenium On Critical Surgical Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

November 16, 2022

Conditions
Critical IllnessSelenium DeficiencyTrace Element DeficiencyAcute AbdomenSepsis
Interventions
DRUG

Selenium Supplement

Zelnite 400mcg/day in normal saline 100ml iv infusion for 7 days

DRUG

normal saline

normal saline 100ml iv infusion for 7 days

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT04662242 - The Prognostic Impact of Selenium On Critical Surgical Patients | Biotech Hunter | Biotech Hunter